Related Experiment Video

Updated: Jun 6, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

[Antitumour effects of bisphosphonates in breast cancer]

Saskia van de Ven1, Judith R Kroep, Neveen A T Hamdy

  • 1Leids Universitair Medisch Centrum, Leiden, Afd. Klinische Oncologie, The Netherlands. s.van_de_ven@lumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|November 19, 2010
PubMed

Insights

Nitrogen-containing bisphosphonates show promise as antitumour agents, potentially inhibiting cancer spread and growth. Further research is needed to explore their synergistic effects with chemotherapy and role in breast cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Metastasis

Context:

  • Bisphosphonates are established treatments for bone resorption.
  • Emerging evidence suggests nitrogen-containing bisphosphonates possess antitumour properties.
  • Skeletal metastases are a common complication of cancer.

Purpose:

  • To review the potential antitumour effects of nitrogen-containing bisphosphonates.
  • To explore their mechanisms of action against cancer cells.
  • To assess their role in combination therapy and neoadjuvant treatment.

Summary:

  • Nitrogen-containing bisphosphonates inhibit osteoclast activity, delaying skeletal metastasis.
  • These agents may also directly inhibit tumour cell proliferation, apoptosis, invasion, and angiogenesis.
  • Preliminary data indicate a potential synergistic antitumour effect when combined with chemotherapy.

Impact:

  • Bisphosphonates represent a potential therapeutic strategy for managing cancer progression beyond bone resorption.
  • Their role in neoadjuvant breast cancer therapy warrants further clinical investigation.
  • Understanding bisphosphonate mechanisms could lead to novel cancer treatment combinations.

More Related Videos

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...